Emergencies: Clinical Trials

14 trials for Emergencies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 2 unknown, 1 active not recruiting. 14 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 114Completed 6, Recruiting 2, Unknown 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1
Phase 24Completed 3, Enrolling by invitation 1

Follow Emergencies: new trials by email Literature Review of Emergencies trials Research Report on Emergencies

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Decision Support Tool to Integrate PrEP Into Emergency Departments
Decision support tool, PrEP Delivery - HIV
Phase 1Not yet recruitingGeorge Washington University1202026-10-012026-10-08
Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial
Vericiguat tablet, Sacubitril / Valsartan - Decompensated Heart Failure
Phase 1RecruitingKhawaja Danish Ali1302026-01-012026-03-02
Comparison of the Efficacy of Diclofenac Sodium and Subcutaneous 5% Dextrose Injection in Low Back Pain.
5% dextrose prolotherapy, Diclofenac 75mg/ml - Low Back Pain, Mechanical
Phase 1 / Phase 2Enrolling by invitationAksaray University Training and Research Hospital1502024-07-152025-02-19
Nebulized Fentanyl in Healthy Volunteers
Fentanyl - Inhalation by facial nebulization, Fentanyl - Nebulisation - Analgesia, Emergencies
Phase 1RecruitingUniversity Hospital, Rouen202024-04-262026-05-11
The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department
Amoxicillin, Study questionnaire - Allergy Amoxicillin, Beta-lactam Allergy Labels
Phase 1Active not recruitingThe Hospital for Sick Children5002023-11-272026-05-07
Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)
Sativex - Malnutrition, Anorexia
Phase 1UnknownOve Andersen172022-03-242022-09-21
ED Initiated Oral Naltrexone for AUD
Emergency Department Initiated Oral Naltrexone - Alcohol Use Disorder
Phase 1CompletedIcahn School of Medicine at Mount Sinai302021-09-282025-08-26
Dexamethasone as an Immediate Intervention
Dexamethasone - Trauma
Phase 1WithdrawnNYU Langone Health2017-01-012017-12-14
Low-dose Ketamine for Acute Pain in the Emergency Department
Ketamine, Placebos, Morphine - Pain
Phase 1UnknownFaculty of Medicine, Sousse1252016-01-012017-01-31
Ondansetron for Pediatric Mild Traumatic Brain Injury
Ondansetron, PLacebo - Traumatic Brain Injury, Brain Concussion
Phase 1CompletedSt. Justine's Hospital162013-03-012015-09-29
Intravenous Fluid for Pediatric Migraine in the Emergency Department
Normal saline - Migraine, Headache
Phase 1 / Phase 2CompletedUniversity of Alberta462010-07-012026-02-06
Ketamine for Low Mood States in the ER
ketamine - Depression, Suicide Ideation
Phase 1CompletedYale University142010-04-012020-08-24
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
Fentanyl, Lansoprazole, Oxycodone - Pain, Fracture, Sprain
Phase 1 / Phase 2CompletedMassachusetts General Hospital602008-08-012017-02-09
Emergency Department Initiated Tobacco Treatment (EDITT)
Behavior change counseling - Tobacco Use
Phase 1 / Phase 2CompletedNational Institute on Drug Abuse (NIDA)752005-12-012017-01-11

Narrower conditions

Agnosia (2)  ·  Pain (2)  ·  Acute Pain (1)  ·  Alcoholism (1)  ·  Anorexia (1)  ·  Brain Concussion (1)  ·  Brain Injuries, Traumatic (1)  ·  Combat Disorders (1)  ·  Depression (1)  ·  Fractures, Bone (1)  ·  Headache (1)  ·  Heart Failure (1)  ·  Low Back Pain (1)  ·  Malnutrition (1)

Broader conditions

Disease Attributes (14)  ·  Pathologic Processes (14)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Signs and Symptoms (6)  ·  Neurologic Manifestations (5)  ·  Nervous System Diseases (4)  ·  Mental Disorders (3)  ·  Pain (3)  ·  Behavior (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Chemically-Induced Disorders (2)  ·  Neurobehavioral Manifestations (2)  ·  Perceptual Disorders (2)  ·  Substance-Related Disorders (2)

Interventions

Ketamine (2)  ·  Amoxicillin (1)  ·  Behavior Therapy (1)  ·  Dexamethasone (1)  ·  Diclofenac (1)  ·  Fentanyl (1)  ·  Lansoprazole (1)  ·  Morphine (1)  ·  Ondansetron (1)  ·  Oxycodone (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Water (1)  ·  nabiximols (1)  ·  oxycodone-acetaminophen (1)

Sponsors

Aksaray University Training and Research Hospital (1)  ·  Faculty of Medicine, Sousse (1)  ·  George Washington University (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Khawaja Danish Ali (1)  ·  Massachusetts General Hospital (1)  ·  NYU Langone Health (1)  ·  National Institute on Drug Abuse (NIDA) (1)  ·  Ove Andersen (1)  ·  St. Justine's Hospital (1)  ·  The Hospital for Sick Children (1)  ·  University Hospital, Rouen (1)  ·  University of Alberta (1)  ·  Yale University (1)

Countries

United States (6)  ·  Canada (3)  ·  Denmark (1)  ·  France (1)  ·  Pakistan (1)  ·  Tunisia (1)  ·  Turkey (Türkiye) (1)

Top investigators

Edwin D Boudreaux, PhD (1)  ·  Ethan Cowan, MD (1)  ·  Gregory L Larkin, MD (1)  ·  Isaac Galatzer-Levy, MD (1)  ·  Jocelyn Gravel, MD (1)  ·  Lawrence P Richer, MD, MSc (1)  ·  Ove Andersen (1)  ·  Rikke L Nielsen (1)  ·  Stephen H Thomas, MD, MPH (1)

Results publications

PMID 19050988, PMID 21557878, PMID 25168404, PMID 28637184, PMID 40069983, PMID 40615143, PMID 42514343